MedPath

广西昌弘制药有限公司

Ownership
-
Established
1993-01-09
Employees
-
Market Cap
-
Website
http://www.gxchanghong.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

20

NMPA:20

Drug Approvals

仙黄胶囊

Approval Number
国药准字Z20090691
Approval Date
Feb 22, 2024
NMPA

Compound Sulfamethoxazole Tablets

Product Name
复方磺胺甲噁唑片
Approval Number
国药准字H45021579
Approval Date
Sep 29, 2020
NMPA

Benorilate Tablets

Product Name
贝诺酯片
Approval Number
国药准字H45021381
Approval Date
Sep 29, 2020
NMPA

Berberine Hydrochloride Tablets

Product Name
盐酸小檗碱片
Approval Number
国药准字H45021584
Approval Date
Sep 29, 2020
NMPA

Ranitidine Hydrochloride Capsules

Product Name
盐酸雷尼替丁胶囊
Approval Number
国药准字H45021380
Approval Date
Sep 29, 2020
NMPA

Metronidazole Tablets

Product Name
甲硝唑片
Approval Number
国药准字H45021581
Approval Date
Sep 29, 2020
NMPA

Kitasamycin Tablets

Product Name
吉他霉素片
Approval Number
国药准字H45021585
Approval Date
Sep 29, 2020
NMPA

Paracetamol Tablets

Product Name
对乙酰氨基酚片
Approval Number
国药准字H45021379
Approval Date
Sep 29, 2020
NMPA

Gliclazide Capsules

Product Name
格列齐特胶囊
Approval Number
国药准字H45021271
Approval Date
Sep 29, 2020
NMPA

Paracetamol Tablets

Product Name
对乙酰氨基酚片
Approval Number
国药准字H45021578
Approval Date
Sep 29, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.